Recombinant Human Erythropoietin in the Treatment of Chronic Anemia of Cancer

Publisher： Karger

E-ISSN： 1421-9662|100|2|115-115

ISSN： 0001-5792

Source： Acta Haematologica, Vol.100, Iss.2, 1998-10, pp. : 115-115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Predicting the Hematopoietic Response to Recombinant Human Erythropoietin (Epoetin Alfa) in the Treatment of the Anemia of Cancer

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 46-53

Karger

Access to resources Recommend Favorite

Recombinant Human Erythropoietin for the Treatment of Anaemia in Patients with Chronic Idiopathic Myelofibrosis

By  

Acta Haematologica, Vol. 117, Iss. 3, 2006-12 ,pp. : 156-161

Karger

Access to resources Recommend Favorite

Effects of Recombinant Human Erythropoietin (rHuEPO) on Tumor Control in Patients with Cancer-Induced Anemia

By  

Oncology Research and Treatment, Vol. 28, Iss. 4, 2005-10 ,pp. : 216-221

Karger

Access to resources Recommend Favorite

Recombinant human epoetin beta in the treatment of renal anemia

By Del Vecchio Lucia   Cavalli Andrea   Pozzoni Pietro   Locatelli Francesco  

Therapy, Vol. 5, Iss. 1, 2008-01 ,pp. : 91-98

Future Medicine

Access to resources Recommend Favorite

The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin

By Devine E. B.   Cross J. T.   Kowdley K. V.   Sullivan S. D.  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1463-1472

Informa Healthcare

Access to resources Recommend Favorite